| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0031182015001249 |
| P698 | PubMed publication ID | 26741253 |
| P50 | author | James Beeson | Q56780488 |
| Philippe Boeuf | Q40960543 | ||
| Freya Fowkes | Q42800053 | ||
| P2860 | cites work | A new world malaria map: Plasmodium falciparum endemicity in 2010 | Q17485680 |
| A long neglected world malaria map: Plasmodium vivax endemicity in 2010 | Q21144495 | ||
| The global distribution of the Duffy blood group | Q24620738 | ||
| The distribution of haemoglobin C and its prevalence in newborns in Africa | Q24633471 | ||
| Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis | Q24633916 | ||
| Acquired immunity to malaria | Q24651173 | ||
| Priming of CD8(+) T Cell Responses to Liver Stage Malaria Parasite Antigens | Q26997355 | ||
| Antigenic variation in Plasmodium falciparum | Q27972540 | ||
| Immunity to non-cerebral severe malaria is acquired after one or two infections | Q28139257 | ||
| Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children | Q28477259 | ||
| G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map | Q28485156 | ||
| Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control | Q28548617 | ||
| The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial | Q28731458 | ||
| Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells | Q28742596 | ||
| Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea | Q28744515 | ||
| The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania | Q28744581 | ||
| High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model | Q28749979 | ||
| The V gene repertoires of classical and atypical memory B cells in malaria-susceptible West African children | Q30301015 | ||
| HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults | Q30388860 | ||
| Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data | Q30596414 | ||
| Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. | Q30670710 | ||
| Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use. | Q31047525 | ||
| Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria | Q31139546 | ||
| Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria | Q31169310 | ||
| Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria | Q33301333 | ||
| Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria | Q33356958 | ||
| Studies on the persistence of malarial antibody response | Q47949783 | ||
| Gamma-globulin and acquired immunity to human malaria | Q47957467 | ||
| Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax | Q47974189 | ||
| Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka. | Q47998885 | ||
| Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting | Q48028402 | ||
| Gradual acquisition of immunity to severe malaria with increasing exposure | Q50983969 | ||
| Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro | Q59065277 | ||
| Immune effector mechanisms in malaria | Q82383609 | ||
| Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis | Q37023452 | ||
| The risk of malarial infections and disease in Papua New Guinean children. | Q37088901 | ||
| Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness | Q37099503 | ||
| A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria | Q37148056 | ||
| Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure | Q37191417 | ||
| Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria | Q37247251 | ||
| Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area | Q37269963 | ||
| Recent insights into humoral and cellular immune responses against malaria | Q37291684 | ||
| Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. | Q37313879 | ||
| Spatial distribution of G6PD deficiency variants across malaria-endemic regions | Q37329332 | ||
| Marked decline in malaria prevalence among pregnant women and their offspring from 1996 to 2010 on the south Kenyan Coast | Q37372620 | ||
| Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau | Q37470249 | ||
| The future for blood-stage vaccines against malaria | Q37471465 | ||
| Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria | Q37521618 | ||
| Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu | Q37548182 | ||
| Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa | Q37581763 | ||
| Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis | Q37619511 | ||
| Dramatic declines in seropositivity as determined with crude extracts of Plasmodium falciparum schizonts between 2000 and 2010 in Dielmo and Ndiop, Senegal | Q37684687 | ||
| B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites | Q37713335 | ||
| A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots | Q37723182 | ||
| Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. | Q37773425 | ||
| Changes in the burden of malaria in sub-Saharan Africa | Q37773536 | ||
| Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets | Q38079322 | ||
| How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection | Q38096725 | ||
| Memory T cells maintain protracted protection against malaria. | Q38202729 | ||
| Correlates of protective immunity following whole sporozoite vaccination against malaria | Q38211625 | ||
| CD8 T-cell-mediated protection against liver-stage malaria: lessons from a mouse model | Q38220815 | ||
| Trying to remember: immunological B cell memory to malaria | Q38321913 | ||
| Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda | Q38865826 | ||
| Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children | Q38881807 | ||
| Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children | Q38882004 | ||
| Identification of hot spots of malaria transmission for targeted malaria control | Q38917779 | ||
| The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens | Q38928381 | ||
| Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severity. | Q38956093 | ||
| An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection | Q36892880 | ||
| Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. | Q36899271 | ||
| Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission | Q36917011 | ||
| Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics | Q36982630 | ||
| Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development | Q36984161 | ||
| Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya | Q37023420 | ||
| Epidemiology of imported malaria give support to the hypothesis of 'long-term' semi-immunity to malaria in sub-Saharan African migrants living in France | Q33410366 | ||
| Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania | Q33449934 | ||
| Rapid assessment of malaria transmission using age-specific sero-conversion rates | Q33475618 | ||
| Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya | Q33487651 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis | Q33529052 | ||
| Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax | Q33533328 | ||
| The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections | Q33587496 | ||
| Kinetics of B cell responses to plasmodium falciparum erythrocyte membrane protein 1 in ghanaian women naturally exposed to malaria parasites | Q33630156 | ||
| Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya | Q33631268 | ||
| BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection | Q33640267 | ||
| Continued decline of malaria in The Gambia with implications for elimination | Q33678743 | ||
| A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali | Q33802641 | ||
| A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray | Q33859633 | ||
| Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure | Q33935818 | ||
| Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers | Q33967206 | ||
| Using serological measures to monitor changes in malaria transmission in Vanuatu | Q33998176 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission | Q34047037 | ||
| Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates | Q34161839 | ||
| Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes | Q34165879 | ||
| Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands | Q34180495 | ||
| Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis | Q34234390 | ||
| Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children | Q34261333 | ||
| Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria | Q34301187 | ||
| Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites | Q34408886 | ||
| Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands. | Q34465321 | ||
| Research priorities for the development and implementation of serological tools for malaria surveillance | Q34500035 | ||
| Antibody and B cell responses to Plasmodium sporozoites | Q34530938 | ||
| Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya | Q34541443 | ||
| Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization | Q34563555 | ||
| High number of previous Plasmodium falciparum clinical episodes increases risk of future episodes in a sub-group of individuals | Q34584404 | ||
| Cytokine and antibody responses to Plasmodium falciparum in naïve individuals during a first malaria episode: effect of age and malaria exposure | Q34598177 | ||
| Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa | Q39115032 | ||
| Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya | Q39130334 | ||
| Patterns in age‐specific malaria incidence in a population exposed to low levels of malaria transmission intensity | Q39140454 | ||
| Epidemiological features and case management practices of imported malaria in northern Italy 1991-1995. | Q39226187 | ||
| Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria | Q39394357 | ||
| Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. | Q39417737 | ||
| Decreasing malaria prevalence and its potential consequences for immunity in pregnant women | Q39517373 | ||
| Dynamics of the antibody response to Plasmodium falciparum infection in African children | Q39589730 | ||
| Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230 | Q39830524 | ||
| Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived | Q40150215 | ||
| Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum | Q40183845 | ||
| Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection | Q40193241 | ||
| Imported malaria in adults and children: epidemiological and clinical characteristics of 380 consecutive cases observed in Verona, Italy | Q40413190 | ||
| Mechanisms of defense against P. falciparum asexual blood stages in humans | Q40656074 | ||
| The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu | Q40661446 | ||
| The relationship of serum gamma-globulin concentration to malaria and sickling | Q41286373 | ||
| Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar. | Q41503667 | ||
| Is immunity to malaria really short-lived? | Q41504897 | ||
| IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life | Q42151954 | ||
| Malaria blood stage suppression of liver stage immunity by dendritic cells | Q42944777 | ||
| Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment | Q43115857 | ||
| Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. | Q43245288 | ||
| Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children | Q43952435 | ||
| The seroepidemiology of malaria in Middle America. I. Longitudinal studies on populations in a low incidence area of El Salvador | Q44140963 | ||
| Local-scale variation in malaria infection amongst rural Gambian children estimated by satellite remote sensing | Q44143530 | ||
| Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection | Q44147641 | ||
| Sexual-stage antibody responses to P. falciparum in endemic populations | Q44167654 | ||
| Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230. | Q44169334 | ||
| Prenatal immune priming in malaria: antigen-specific blastogenesis of cord blood lymphocytes from neonates born in a setting of holoendemic malaria. | Q44484949 | ||
| Pregnancy and malaria exposure are associated with changes in the B cell pool and in plasma eotaxin levels | Q45181356 | ||
| Sero-epidemiological studies on population groups previously exposed to malaria | Q46665247 | ||
| B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area | Q46888171 | ||
| Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea | Q46928584 | ||
| A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease | Q46950134 | ||
| Action of Malarial Antibody in vitro | Q47680023 | ||
| Profiling the antibody immune response against blood stage malaria vaccine candidates | Q47832842 | ||
| Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. | Q47837358 | ||
| Cross-species interactions between malaria parasites in humans. | Q47858494 | ||
| Clinical presentation and complications of Plasmodium falciparum malaria in two populations: travelers and immigrants | Q47868053 | ||
| Naturally acquired circumsporozoite antibodies and their role in protection in endemic falciparum and vivax malaria | Q47874479 | ||
| Frequent and persistent, asymptomatic plasmodium falciparum infections in african infants, characterized by multilocus genotyping | Q47877169 | ||
| Acquired Immune Responses to Plasmodium falciparum Merozoite Surface Protein-1 in the Human Fetus | Q47896543 | ||
| Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications | Q47911975 | ||
| Severe imported malaria in adults: retrospective study of 20 cases | Q47915802 | ||
| Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection | Q34796738 | ||
| Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response | Q34955461 | ||
| Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity | Q34975629 | ||
| A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children | Q34990680 | ||
| Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic | Q35016677 | ||
| Protection of Malian children from clinical malaria is associated with recognition of multiple antigens | Q35094826 | ||
| Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir | Q35125678 | ||
| Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence | Q35128307 | ||
| RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites | Q35148353 | ||
| Changing patterns of malaria during 1996-2010 in an area of moderate transmission in southern Senegal | Q35177727 | ||
| Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria | Q35213495 | ||
| New antigens for a multicomponent blood-stage malaria vaccine | Q35216634 | ||
| Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection | Q35439859 | ||
| Metabolic properties of IgG subclasses in man | Q35576283 | ||
| Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans | Q35586865 | ||
| Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity | Q35628510 | ||
| Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function | Q35649750 | ||
| High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections | Q35661211 | ||
| Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models | Q35739115 | ||
| Plasmodium falciparum Malaria in the Peruvian Amazon, a Region of Low Transmission, Is Associated with Immunologic Memory | Q35867604 | ||
| Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008 | Q35877370 | ||
| Does malaria suffer from lack of memory? | Q35884250 | ||
| Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test | Q35913794 | ||
| New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women | Q36330969 | ||
| Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. | Q36368911 | ||
| Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria | Q36378330 | ||
| Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human Antibodies | Q36380869 | ||
| Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? | Q36391845 | ||
| Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific | Q36539692 | ||
| Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates | Q36540250 | ||
| Chronic Exposure to Plasmodium falciparum Is Associated with Phenotypic Evidence of B and T Cell Exhaustion | Q36545994 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. | Q36759784 | ||
| P433 | issue | 2 | |
| P921 | main subject | malaria transmission | Q56928847 |
| P304 | page(s) | 139-153 | |
| P577 | publication date | 2016-01-07 | |
| P1433 | published in | Parasitology | Q15753259 |
| P1476 | title | Immunity to malaria in an era of declining malaria transmission | |
| P478 | volume | 143 |
| Q47716363 | Adjunctive therapy for severe malaria: a review and critical appraisal |
| Q40106428 | Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic |
| Q41995596 | Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study |
| Q41991578 | Declining malaria transmission differentially impacts on the maintenance of humoral immunity to Plasmodium falciparum in children |
| Q64067675 | Dendritic Cell Responses and Function in Malaria |
| Q89621117 | Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute Plasmodium falciparum Malaria |
| Q61805081 | Different Life Cycle Stages of Induce Contrasting Responses in Dendritic Cells |
| Q39230991 | Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance |
| Q33791653 | Effectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study |
| Q90594901 | Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD-scid IL2Rγnull Mouse Model of Malaria |
| Q55248535 | Factors influencing the induction of high affinity antibodies to Plasmodium falciparum merozoite antigens and how affinity changes over time. |
| Q30249044 | Global Epidemiology of Plasmodium vivax |
| Q56378965 | Malaria |
| Q93075230 | Measuring malaria morbidity in an area of seasonal transmission: Pyrogenic parasitemia thresholds based on a 20-year follow-up study |
| Q38613292 | Naturally acquired antibody response to Plasmodium falciparum describes heterogeneity in transmission on islands in Lake Victoria |
| Q38782812 | Obesity and Diabetes as Risk Factors for Severe Plasmodium falciparum Malaria: Results from a Swedish Nationwide Study |
| Q37747993 | Patterns of inflammatory responses and parasite tolerance vary with malaria transmission intensity |
| Q92574146 | Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination |
| Q47093575 | Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria |
| Q56341482 | The 2015-2016 malaria epidemic in Northern Uganda; what are the implications for malaria control interventions? |
| Q94460590 | The role of complement immune response on artemisinin-based combination therapy in a population from malaria endemic region of Western Kenya |
| Q47132201 | malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication |
Search more.